QNCX: Quince Therapeutics Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Quince Therapeutics Inc (QNCX).

OverviewDividends

$82.28M Market Cap.

As of 05/14/2025 5:00 PM ET (MRY) • Disclaimer

QNCX Market Cap. (MRY)


QNCX Shares Outstanding (MRY)


QNCX Assets (MRY)


Total Assets

$114.48M

Total Liabilities

$84.33M

Total Investments

$34.57M

QNCX Income (MRY)


Revenue

$0

Net Income

-$56.83M

Operating Expense

$53.30M

QNCX Cash Flow (MRY)


CF Operations

-$31.90M

CF Investing

$21.91M

CF Financing

-$4.78M

QNCX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$114,478,000 (-31.82%)

$167,900,000 (61.58%)

$103,910,000 (-22.01%)

$133,228,000 (-29.68%)

Assets Current

$44,036,000 (-43.14%)

$77,440,000 (-17.40%)

$93,748,000 (-16.05%)

$111,673,000 (-19.00%)

Assets Non-Current

$70,442,000 (-22.13%)

$90,460,000 (790.18%)

$10,162,000 (-52.86%)

$21,555,000 (-58.23%)

Goodwill & Intangible Assets

$60,045,000 (-26.14%)

$81,297,000 (1277.92%)

$5,900,000 (0%)

$0 (0%)

Shareholders Equity

$30,146,000 (-64.57%)

$85,084,000 (-15.42%)

$100,593,000 (-15.17%)

$118,586,000 (-31.16%)

Property Plant & Equipment Net

$813,000 (31.34%)

$619,000 (-9.50%)

$684,000 (-52.10%)

$1,428,000 (29.70%)

Cash & Equivalents

$6,212,000 (-70.07%)

$20,752,000 (-53.45%)

$44,579,000 (-36.06%)

$69,724,000 (4.31%)

Accumulated Other Comprehensive Income

-$35,000 (-101.15%)

$3,047,000 (1154.33%)

-$289,000 (-265.82%)

-$79,000 (-125.24%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$34,572,000 (-36.34%)

$54,307,000 (10.42%)

$49,180,000 (-13.74%)

$57,011,000 (-51.46%)

Investments Current

$34,572,000 (-36.34%)

$54,307,000 (19.09%)

$45,602,000 (22.99%)

$37,078,000 (-44.64%)

Investments Non-Current

$0 (0%)

$0 (0%)

$3,578,000 (-82.05%)

$19,933,000 (-60.50%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$2,903,000 (42.79%)

$2,033,000 (256.67%)

$570,000 (-88.39%)

$4,911,000 (38.14%)

Accumulated Retained Earnings (Deficit)

-$376,472,000 (-17.78%)

-$319,644,000 (-10.89%)

-$288,259,000 (-21.83%)

-$236,599,000 (-61.33%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$4,963,000 (-6.43%)

$5,304,000 (2038.71%)

$248,000 (0%)

$0 (0%)

Total Debt

$14,715,000 (7.02%)

$13,750,000 (0%)

$0 (0%)

$420,000 (101.92%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$14,715,000 (7.02%)

$13,750,000 (0%)

$0 (0%)

$420,000 (101.92%)

Total Liabilities

$84,332,000 (1.83%)

$82,816,000 (2396.71%)

$3,317,000 (-77.35%)

$14,642,000 (-14.89%)

Liabilities Current

$7,278,000 (-23.97%)

$9,572,000 (211.89%)

$3,069,000 (-78.42%)

$14,222,000 (-16.32%)

Liabilities Non-Current

$77,054,000 (5.20%)

$73,244,000 (29433.87%)

$248,000 (-40.95%)

$420,000 (101.92%)

QNCX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$17,580,000 (-0.65%)

$17,695,000 (-31.97%)

$26,012,000 (-11.89%)

$29,523,000 (67.88%)

Research & Development Expense

$18,590,000 (96.78%)

$9,447,000 (-62.48%)

$25,178,000 (-58.59%)

$60,795,000 (-0.84%)

Operating Expenses

$53,300,000 (61.31%)

$33,042,000 (-36.48%)

$52,015,000 (-42.41%)

$90,318,000 (14.48%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$87,000 (144.16%)

-$197,000 (30.63%)

-$284,000 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$56,828,000 (-81.07%)

-$31,385,000 (39.25%)

-$51,660,000 (42.56%)

-$89,945,000 (-17.04%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$56,828,000 (-81.07%)

-$31,385,000 (39.25%)

-$51,660,000 (42.56%)

-$89,945,000 (-17.04%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$56,828,000 (-81.07%)

-$31,385,000 (39.25%)

-$51,660,000 (42.56%)

-$89,945,000 (-17.04%)

Weighted Average Shares

$43,262,269 (16.18%)

$37,237,149 (11.17%)

$33,496,534 (12.71%)

$29,718,506 (1.86%)

Weighted Average Shares Diluted

$43,262,269 (16.18%)

$37,237,149 (11.17%)

$33,496,534 (12.71%)

$29,718,506 (1.86%)

Earning Before Interest & Taxes (EBIT)

-$56,741,000 (-79.66%)

-$31,582,000 (39.20%)

-$51,944,000 (42.25%)

-$89,945,000 (-17.04%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$53,300,000 (-61.31%)

-$33,042,000 (36.48%)

-$52,015,000 (42.41%)

-$90,318,000 (-14.48%)

QNCX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$21,908,000 (480.48%)

-$5,758,000 (-131.99%)

$18,002,000 (-69.46%)

$58,952,000 (212.44%)

Net Cash Flow from Financing

-$4,775,000 (-3439.16%)

$143,000 (-79.77%)

$707,000 (-89.62%)

$6,808,000 (-94.27%)

Net Cash Flow from Operations

-$31,904,000 (-74.42%)

-$18,292,000 (58.46%)

-$44,038,000 (30.02%)

-$62,932,000 (-23.84%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$14,540,000 (38.98%)

-$23,827,000 (5.24%)

-$25,145,000 (-972.18%)

$2,883,000 (-81.55%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

-$2,116,000 (-119.98%)

$10,593,000 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$22,165,000 (720.52%)

-$3,572,000 (-147.81%)

$7,472,000 (-87.36%)

$59,132,000 (212.89%)

Capital Expenditure

-$257,000 (-267.14%)

-$70,000 (-11.11%)

-$63,000 (65.00%)

-$180,000 (-246.15%)

Issuance (Repayment) of Debt Securities

$0 (0%)

-$6,000 (87.76%)

-$49,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$225,000 (51.01%)

$149,000 (-80.29%)

$756,000 (-88.90%)

$6,808,000 (-94.27%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$231,000 (188.75%)

$80,000 (-56.52%)

$184,000 (234.55%)

$55,000 (0%)

Share Based Compensation

$4,746,000 (-9.08%)

$5,220,000 (-68.59%)

$16,618,000 (-44.33%)

$29,853,000 (106.31%)

Depreciation Amortization & Accretion

$186,000 (-42.24%)

$322,000 (57.84%)

$204,000 (-40.70%)

$344,000 (3.61%)

QNCX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-115.80% (-218.13%)

-36.40% (25.41%)

-48.80% (25.38%)

-65.40% (-66.84%)

Return on Average Assets (ROAA)

-42.50% (-47.57%)

-28.80% (37.66%)

-46.20% (20.89%)

-58.40% (-60.44%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-88.60% (-67.80%)

-52.80% (45.40%)

-96.70% (29.47%)

-137.10% (-124.02%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.43 (-14.16%)

-1.25 (-201.93%)

-0.41 (90.06%)

-4.17 (60.57%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

2.73 (415.88%)

0.53 (131.00%)

0.23 (-92.80%)

3.18 (-33.15%)

Debt to Equity Ratio (D/E)

2.8 (187.46%)

0.97 (2848.48%)

0.03 (-73.17%)

0.12 (23.00%)

Earnings Per Share (EPS)

-1.31 (-55.95%)

-0.84 (45.45%)

-1.54 (49.17%)

-3.03 (-15.21%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.74 (-50.71%)

-0.49 (62.57%)

-1.32 (37.99%)

-2.12 (-21.79%)

Book Value Per Share (BVPS)

0.7 (-69.50%)

2.29 (-23.91%)

3 (-24.74%)

3.99 (-32.42%)

Tangible Assets Book Value Per Share (TABVPS)

1.26 (-45.92%)

2.33 (-20.51%)

2.93 (-34.73%)

4.48 (-30.97%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (-100.00%)

-1 (0%)

0 (0%)

-4 (60.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.68 (-124.47%)

-0.75 (-542.60%)

0.17 (104.80%)

-3.52 (64.34%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

6.05 (-25.20%)

8.09 (-73.52%)

30.55 (289.03%)

7.85 (-3.19%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$32,161,000 (-75.15%)

-$18,362,000 (58.36%)

-$44,101,000 (30.12%)

-$63,112,000 (-24.07%)

Enterprise Value (EV)

$94,957,072 (306.14%)

$23,380,394 (367.92%)

-$8,726,543 (-102.77%)

$315,458,413 (-58.24%)

Earnings Before Tax (EBT)

-$56,741,000 (-79.66%)

-$31,582,000 (39.20%)

-$51,944,000 (42.25%)

-$89,945,000 (-17.04%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$56,555,000 (-80.92%)

-$31,260,000 (39.58%)

-$51,740,000 (42.26%)

-$89,601,000 (-17.10%)

Invested Capital

$55,658,000 (-20.52%)

$70,029,000 (39.05%)

$50,362,000 (1.33%)

$49,702,000 (-53.04%)

Working Capital

$36,758,000 (-45.84%)

$67,868,000 (-25.16%)

$90,679,000 (-6.95%)

$97,451,000 (-19.37%)

Tangible Asset Value

$54,433,000 (-37.15%)

$86,603,000 (-11.64%)

$98,010,000 (-26.43%)

$133,228,000 (-29.68%)

Market Capitalization

$82,283,072 (82.80%)

$45,012,394 (95.46%)

$23,029,457 (-93.89%)

$377,055,413 (-53.99%)

Average Equity

$49,055,750 (-43.17%)

$86,326,000 (-18.37%)

$105,759,000 (-23.06%)

$137,450,500 (-29.85%)

Average Assets

$133,779,500 (22.89%)

$108,860,000 (-2.73%)

$111,920,000 (-27.39%)

$154,139,000 (-27.00%)

Invested Capital Average

$64,037,750 (7.06%)

$59,813,250 (11.37%)

$53,706,750 (-18.15%)

$65,613,750 (-47.72%)

Shares

44,001,643 (2.64%)

42,868,947 (18.65%)

36,130,306 (20.93%)

29,877,608 (1.29%)